Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octagam 10% in adult idiopathic thrombocytopenic purpura
2005-003552-35Phase 3Completed
- Sponsor
- Octapharma
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Human normal immunoglobulin G in immune thrombocytopenia (ITP), sponsored by Octapharma. Primary endpoint: Platelet response within 7 days. Started Jan 2006; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on 2005-003552-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003552-35.